A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/5365 (2006.01) A61K 31/424 (2006.01) A61P 15/10 (2006.01)
Patent
CA 2746824
Administration .beta.-lactam compounds, including of inhibitors of certain bacterial peptidases have been found to provide significant neurotropic effects in warm-blooded vertebrates evidenced inter alia by anxiolytic and anti- aggressive behavior and enhanced cognition believed to be mediated by inhibition of neurogenic NAALADase and related enzyme activity. .beta.-Lactam antibiotics and .beta.- lactamase inhibitors have been found to exhibit potent NAALADase inhibition, and those compounds with blood brain barrier transport are effective inhibitors of neurogenic NAALADase with significant neuro-therapeutic effects. .beta.-Lactam compounds are useful for treatment of numerous disease states associated with glutamate abnormalities. Therapeutic methods for using such compounds and their pharmaceutical formulations are described. Specifically, the invention relates to use of a .beta.-lactam compound selected from clavulanic acid, moxalactam, a pharmaceutically acceptable salt thereof, or an active ester form thereof, for use in the treatment of a sexual disorder.
Revaax Pharmaceuticals Llc
Smart & Biggar
LandOfFree
Neurotherapeutic composition and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neurotherapeutic composition and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neurotherapeutic composition and method will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1926534